These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35309990)

  • 1. Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2.
    Friedrich M; Pfeifer G; Binder S; Aigner A; Vollmer Barbosa P; Makert GR; Fertey J; Ulbert S; Bodem J; König EM; Geiger N; Schambach A; Schilling E; Buschmann T; Hauschildt S; Koehl U; Sewald K
    Front Bioeng Biotechnol; 2022; 10():801870. PubMed ID: 35309990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence.
    Tolksdorf B; Nie C; Niemeyer D; Röhrs V; Berg J; Lauster D; Adler JM; Haag R; Trimpert J; Kaufer B; Drosten C; Kurreck J
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells.
    Sartaj Sohrab S; Aly El-Kafrawy S; Ibraheem Azhar E
    J King Saud Univ Sci; 2022 Jun; 34(4):102049. PubMed ID: 35493709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of replication and infection of severe acute respiratory syndrome-associated coronavirus with plasmid-mediated interference RNA.
    Ni B; Shi X; Li Y; Gao W; Wang X; Wu Y
    Antivir Ther; 2005; 10(4):527-33. PubMed ID: 16038478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.
    Li T; Zhang Y; Fu L; Yu C; Li X; Li Y; Zhang X; Rong Z; Wang Y; Ning H; Liang R; Chen W; Babiuk LA; Chang Z
    Gene Ther; 2005 May; 12(9):751-61. PubMed ID: 15772689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
    Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains.
    Madanagopal P; Muthukumar H; Thiruvengadam K
    Comput Biol Chem; 2022 Jun; 98():107687. PubMed ID: 35537364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2.
    Shawan MMAK; Sharma AR; Bhattacharya M; Mallik B; Akhter F; Shakil MS; Hossain MM; Banik S; Lee SS; Hasan MA; Chakraborty C
    Infect Genet Evol; 2021 Sep; 93():104951. PubMed ID: 34089909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2.
    Saadat KASM
    Gene Rep; 2022 Mar; 26():101512. PubMed ID: 35071824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene silencing of endothelial von Willebrand factor reduces the susceptibility of human endothelial cells to SARS-CoV-2 infection.
    Furini G; De Carli A; Fonnesu R; Spezia PG; Scebba F; Pistello M; Lai M; Lionetti V
    FEBS J; 2023 Sep; 290(17):4300-4315. PubMed ID: 37098810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
    de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
    J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells.
    Basu A; Penumutchu S; Nguyen K; Mbonye U; Tolbert BS; Karn J; Komar AA; Mazumder B
    J Virol; 2022 Jan; 96(2):e0167821. PubMed ID: 34757848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.
    Hasan M; Ashik AI; Chowdhury MB; Tasnim AT; Nishat ZS; Hossain T; Ahmed S
    Inform Med Unlocked; 2021; 24():100569. PubMed ID: 33846694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.
    Li Y; Wang H; Tang X; Fang S; Ma D; Du C; Wang Y; Pan H; Yao W; Zhang R; Zou X; Zheng J; Xu L; Farzan M; Zhong G
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
    Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread.
    Ambike S; Cheng CC; Feuerherd M; Velkov S; Baldassi D; Afridi SQ; Porras-Gonzalez D; Wei X; Hagen P; Kneidinger N; Stoleriu MG; Grass V; Burgstaller G; Pichlmair A; Merkel OM; Ko C; Michler T
    Nucleic Acids Res; 2022 Jan; 50(1):333-349. PubMed ID: 34928377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.
    Idris A; Davis A; Supramaniam A; Acharya D; Kelly G; Tayyar Y; West N; Zhang P; McMillan CLD; Soemardy C; Ray R; O'Meally D; Scott TA; McMillan NAJ; Morris KV
    Mol Ther; 2021 Jul; 29(7):2219-2226. PubMed ID: 33992805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.
    Artman C; Brumfield KD; Khanna S; Goepp J
    PLoS One; 2021; 16(5):e0252399. PubMed ID: 34048457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
    Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
    J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.